Summary
Following 2–4 years of hospitalization, the mental and physical ability of 21 patients with typical idiopathic PD, 10 patients with atypical Parkinson's syndrome and signs of cerebral arteriosclerosis, 29 patients with MID, and 14 patients with senile dementia of the Alzheimer type were evaluated according to various rating scales. All idiopathic parkinsonian patients had suffered from the disease for over 8 years. All patients were over 70 years of age and continuously subjected to the same environment. EEG and CT was performed. A rating scale consisting of 18 items for evaluation of the mental and physical capacity and ability to cope with daily psychosocial demands was used for each patient. Statistically highly significant differences resulted between the relative good mental ability of patients with idiopathic Parkinson's syndrome, with the exception of some brief pharmacotoxic psychoses, and the lower rating scores of patients with senile dementia of Alzheimer type and multiple infarction dementia. A smaller subgroup of patients with Parkinson's syndrome and additional focal signs in the neurological status and EEG showed moderate mental functional loss and a more frequent incidence of pharmacotoxic psychoses than the patients with idiopathic PD. Just as few congruencies of mental ability were found between patients with idiopathic, typical PD and patients with senile dementia of the Alzheimer type as between idiopathic PD and MID. Permanent dementia is not characteristic of patients with typical idiopathic PD even in advanced age. It is, however, for patients with MID and SDAT.
Similar content being viewed by others
References
Alvord, E. D., Forno, L., Kusske, J. A., Kaufmann, R. J., Rhodes, J. S., Goetowski, C. R.: The Pathology of Parkinsonism. A Comparison of Degeneration in Cerebral Cortex and Brainstem. Adv. Neurol.5, 175–193 (1974).
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorder, 3rd ed. Washington D. C.: APA. 1980.
Becker, H., Grau, H., Schneider, E.: CT Examination Series of Parkinson Patients. In: Cranial Computerized Tomography (Larksch, W., Kazner, E., eds.), pp. 249–251. Berlin-Heidelberg-New York: Springer. 1976.
Bergmann, K., Proctor, S., Prudham, D.: Symptom Profiles in Hospital and Community Resident Elderly Persons with Dementia. In: Brain Function in Old Age (Hofmeister, F., Müller, C., eds.), pp. 60–67. Berlin-Heidelberg-New York: Springer. 1979.
Berner, P.: Psychiatrische Systematik, pp. 220–223. Bern: Hans Huber. 1977.
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., Seitelberger, F.: Brain Dopamine and the Syndromes of Parkinson and Huntington. J. Neurol. Science20, 415–455 (1973).
Billenkamp, K.: Untersuchungen zur Psychologie des Parkinsonismus. Arch. Psychiat. Nervenkr.198, 673–686 (1959).
Billenkamp, K.: Experimenteller Beitrag zur Frage des Antriebsverhaltens bei Parkinsonkranken. Arch. Psychiat. Nervenkr.203, 270–279 (1962).
Birkmayer, W., Danielczyk, W., Neumayer, E., Riederer, P.: Nucleus ruber and L-DOPA psychosis. Biochemical postmortem findings. J. Neural Transm.35, 93–116 (1974).
Bleuler, E.: Lehrbuch der Psychiatrie, 9th ed. (Bleuler, M., ed.), pp. 188–189. Berlin-Göttingen-Heidelberg: Springer. 1955.
Boller, F., Mizutani, T., Roessmann, U., Gambetti, P.: Parkinson disease, dementia and Alzheimer disease. Clinico-pathological correlations. Ann. Neurol.7, 329–335 (1979).
Bostroem, A.: Zum Verständnis gewisser psychischer Veränderungen bei Kranken mit Parkinsonschem Symptomenkomplex. Z. ges. Neurol. Psychiat.76, 444–460 (1922).
Carlsson, A.: Aging and Brain Neurotransmitters. In: Funktionsstörungen des Gehirns im Alter (Platt, D., ed.), pp. 67–81. Stuttgart-New York: F. K. Schattauer. 1981.
Danielczyk, W., Riederer, P., Seemann, D.: Benign and malignant type of Parkinson's disease: clinical and pathophysiological characterization. J. Neural Transm., Suppl. 16, pp. 199–210. Wien-New York: Springer. 1980.
Danielczyk, W.: Akute pharmakotoxische Psychosen bei chronischen zerebralen Erkrankungen. Wien. med. Wschr., Suppl. 55 (1979).
Danielczyk, W., Riederer, P., Seemann, D.: Intravenous and Oral Lisuride in Treatment of Parkinson's Syndrome. Abstracts of the 12th World Congress of Neurology, Kyoto, Japan, 1981, p. 366. Amsterdam-Oxford-Princeton: Excerpta Medica. 1981.
Earnest, M. P., Heaton, R. K., Wilkinson, W. E., Manke, W. F.: Cortical atrophy, ventricular enlargement and intellectual impairment in the aged. Neurology (Minneap.)29, 1138–1143 (1979).
Ehringer, H., Hornykiewicz, O.: Verteilung von Noradrenalin und Dopamin im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Wien. klin. Wschr.72, 1236 (1960).
Forno, L. S., Alvord jr., E. C.: The pathology of Parkinsonism. In: Recent Advances in Parkinson's Disease (McDowell, F. H., Markham, C. H., eds.), pp. 120–130. Philadelphia: F. A. Davis. 1971.
Fünfgeld, E. W.: Psychopathologie und Klinik des Parkinsonismus vor und nach stereotaktischen Operationen (Monographien aus dem Gesamtgebiete der Neurologie und Psychiatrie 119), pp. 93–94. Berlin-Heidel-berg-New York: Springer. 1967.
Gerstenbrand, F., Poewe, W., Aichner, F.: Clinical Utilization of MIF-1. In: Central Nervous System Effects of Hypothalamic Hormones and Other Peptides (Collu, R., Barbeau, A., Ducharme, J. R., eds.), p. 415. New York: Raven Press. 1979.
Gottfries, D. G., Adolfsson, R., Aguilonius, S. M., Carlsson, A., Oreland, L., Svennerholm, L., Windlad, B.: Parkinsonism and Dementia disorders of Alzheimer Type: Similarities and Differences. In: Parkinson's Disease. Proceedings of the Northern European Symposium on Parkinson's Disease, Helsinki, November 6–8, 1979 (Rinne, U. K., Klingler, M., Stamm, G., eds.), pp. 197–208. Amsterdam-New York: Elsevier/North-Holland Biomedical Press. 1980.
Hirano, A., Kurland, L. T., Vrooth, R. S., Lessei, N.: Parkinsonism-dementia complex, an epidemic disease on the island of Guam. I. Clinical features. Brain84, 642–661 (1964).
Ikeda, K., Ikeda, S., Yoshimura, T., Kato, H., Namba, M.: Ideopathic Parkinsonism with Lewy-type inclusions in cerebral cortex. Acta neuropath.41, 165–168 (1978).
Jakob, H.: Neuropathologie des Parkinson-Syndroms und die Seneszenz des Gehirns. In: Langzeitbehandlung des Parkinson-Syndroms (Fischer, P. A., ed.), pp. 5–25. Stuttgart-New York: F. K. Schattauer. 1978.
Jakobi, P., Fischer, P. A., Schneider, E.: Kognitive Störungen von Parkinson-Patienten. In: Langzeitbehandlung des Parkinson-Syndroms (Fischer, P. A., ed.), pp. 219–223. Stuttgart-New York: F. K. Schattauer. 1978.
Jellinger, K., Grisold, W.: Zur Frage der Hirnatrophie bei Parkinson-Syndrom (Abstr.) Zbl. allg. Path. path. Anat.125, 567–568 (1981).
Jellinger, K., Grisold, W., Vollmer, R.: Hirnatrophie bei M. Parkinson und (Prä)-seniler Demenz. In: Festschrift für H. Reisner (Schnaberth, G., ed.). Stuttgart-New York: G. Thieme. In press.
König, H.: Zur Psychopathologie der Paralysis agitans. Arch. Psychiat. Nervenkr.50, 283–305 (1912).
Ladurner, G., Bertha, G., Pieringer, W., Lytwin, H., Lechner, H.: Klinische Unterscheidungskriterien bei vasculärer (Multiinfarkt) und primär degenerativer Demenz (Alzheimer). Nervenarzt52, 401–404 (1981).
Liebermann, A., Dziatolowski, M., Kupersmith, M., Serby, M., Goodgold, A., Korein, J., Goldstein, M.: Dementia in Parkinson's disease. Ann. Neurol.6, 355–359 (1979).
Martin, W. E., Loewenson, R. B., Resch, J. A., Baker, A. B.: Parkinson disease: Clinical analysis of 100 patients. Neurology (Minneap.)23, 783–790 (1973).
Meese, W., Kluge, W., Grumme, T., Hopfenmüller, W.: CT evaluation of the CST-spaces of healthy persons. Neuroradiol.10, 131–136 (1980).
Parkinson, J.: An Essay on the Shaking Palsy. London: Sherwood, Neely and Jones. 1817.
Portin, R., Raininko, R., Rinne, U. K.: Neuropsychological disturbances and brain atrophy in parkinsonian patients. In: Abstracts of the 12th World Congress of Neurology, Kyoto, Japan, 1981, p. 16. Amsterdam-Oxford-Princeton: Excerpta Medica. 1981.
Reisner, T., Brunner, G., Schnaberth, G., Maly, J.: Computertomographische Erfassung der malignen Verlaufsform des Parkinsonsyndrom. In: Fortschritte der technischen Medizin in der neurologischen Diagnostik und Therapie (Reisner, H., Schnaberth, eds.), pp. 73–75. Vienna: Neurol. Univ. Clinic. 1980.
Riederer, P., Jellinger, K.: Zur Bedeutung der Seneszenz zerebraler Neurotransmitter für das Parkinson-Syndrom. In: Parkinson-Syndrom: Kombinations- und Begleittherapien (Fischer, P. A., ed.), pp. 34–53. Stuttgart-New York: F. K. Schattauer. 1980.
Schneider, E., Fischer, P. A., Becker, H.: Zur Relevanz extranigraler Hirnläsionen bei Parkinsonkranken. In: Langzeitbehandlung des Parkinson-Syndroms (Fischer, P. A., ed.), pp. 115–129. Stuttgart-New York: F. K. Schattauer. 1978.
Sroka, H., Elizau, T. S., Yahr, M. D., Burger, A., Mendoza, M. R.: Organic mental syndrome and confusional states in Parkinson's disease. Arch. Neurol.38, 339–342 (1981).
Sweet, R. D., McDowell, F. H., Fergenson, J. S., Loranger, A. W., Goodell, H.: Mental symptoms in Parkinson's disease during chronic treatment with levodopa. Neurology (Minneap.)26, 305–310 (1976).
Wang, H. S.: Neuropsychiatric Procedures for the Assessment of Alzheimer's Disease, Senile Dementia and Related Disorders. In: Aging (Miller, N. E., Cohen, G. D., eds.), Vol.15: Clinical Aspects of Alzheimer's Disease and Senile Dementia, pp. 85–100. New York: Raven Press. 1981.
Wang, H. S.: Dementia of Old Age. In: Aging and Dementia (Smith, W. L., Kinsbourne, eds.), pp. 1–24. New York: Spectrum. 1977.
Yoshimura, M.: Kortikale Veränderungen bei Paralysis agitans (Abstr.) Zbl. allg. Path. patholol. Anat.125, 568 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Danielczyk, W. Various mental behavioral disorders in Parkinson's disease, primary degenerative senile dementia, and multiple infarction dementia. J. Neural Transmission 56, 161–176 (1983). https://doi.org/10.1007/BF01243275
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01243275